Enteral Feeding Formulas Market Size to Attain USD 12.51 Bn by 2033

The global enteral feeding formulas market size accounted for USD 7.26 billion in 2023 and is anticipated to hit around USD 12.51 billion by 2033, growing at a CAGR of 5.59% from 2024 to 2033.

Enteral Feeding Formulas Market Size 2024 to 2033

The enteral feeding formulas market involves the production and distribution of nutritional products that are designed to be delivered directly into the gastrointestinal tract via feeding tubes. These formulas are used to provide essential nutrients to individuals who cannot consume food orally due to medical conditions such as neurological disorders, cancer, or gastrointestinal diseases. The market includes a wide variety of products, such as standard formulas, specialized formulas for specific conditions, and modular formulas that can be tailored to meet individual nutritional needs.

Growth Factors:

The enteral feeding formulas market is experiencing growth due to several factors. An aging population worldwide has led to an increase in chronic diseases such as cancer, diabetes, and other conditions that may require enteral feeding. Additionally, advancements in healthcare technology and increased awareness of the benefits of enteral nutrition are contributing to market expansion. The market is also supported by a rise in healthcare spending and a growing number of healthcare facilities offering enteral nutrition as a part of patient care.

Region Insights:

Regionally, the enteral feeding formulas market is expected to see significant growth in North America and Europe due to well-established healthcare infrastructure and higher healthcare spending. In these regions, there is also a greater prevalence of chronic diseases that necessitate enteral nutrition. The Asia-Pacific region is anticipated to experience the highest growth rate due to increasing healthcare investments, a rising geriatric population, and improved access to healthcare services. Latin America and the Middle East & Africa are also expected to see moderate growth as healthcare systems develop and awareness of enteral nutrition increases.

Drivers:

The primary drivers of the enteral feeding formulas market include the growing prevalence of chronic diseases and an aging population. Additionally, the convenience and efficiency of enteral feeding formulas make them an attractive option for patients who cannot eat orally. The development of innovative products and new formulations tailored to specific medical conditions also supports market growth.

Opportunities:

The market presents several opportunities for growth, such as the development of more specialized formulas for various medical conditions. Companies can also explore untapped markets in emerging regions with a growing demand for healthcare services. Advances in technology, such as telehealth and remote monitoring, could facilitate the delivery of enteral feeding formulas to patients in their homes, creating additional market opportunities.

Challenges:

Despite the growth prospects, the enteral feeding formulas market faces challenges such as stringent regulatory requirements for product approval and distribution. Additionally, the high cost of some specialized formulas may limit access for some patients. Competition from alternative forms of nutrition, such as parenteral nutrition, can also pose a challenge to the market's growth. Addressing these challenges will be essential for market participants to maintain and expand their market presence.

Enteral Feeding Formulas Market Recent Developments

In September 2023, Abbott announced the plan to boost the manufacturing of various adult enteral formulas for the retail market to counteract low supply in the institutional sector.
In February 2023, Nestlé and EraCal Therapeutics initiated a research collaboration to identify novel nutraceuticals for controlling food intake.
In September 2022, Kate Farms introduced Adult Standard 1.4, a high-calorie medical formula now offered in chocolate. This product is designed to assist in weight gain, weight maintenance, and improved tolerance while providing a delicious taste.
In September 2022, Kate Farms raised $75 million in a Series C funding round led by life-science investor Novo Holdings. With this, Kate Farms will be able to increase its efforts in developing plant-based clinical nutrition research, product innovation, and development into more channels.

Enteral Feeding Formulas Market Companies

Nestlé S.A.
Abbott Laboratories
Mead Johnson Nutrition Company
Fresenius Kabi AG
Danone S.A.
Victus Inc.
Hormel Foods, LLC
B. Braun Melsungen AG
Global Health Product Inc.
Aveanna Healthcare
Meiji Holdings Co., Ltd.
Nutricia

Segments Covered in the Report

By Product

Standard Formula
Disease-specific Formulas
- Alzheimer’s
- Nutrition Deficiency
- Cancer Care
- Diabetes
- Chronic Kidney Diseases
- Orphan Diseases
- Dysphagia
- Pain Management
- Malabsorption/GI Disorder/Diarrhea
- Others